By linking molecular-level recognition with computational signal interpretation, this review highlights the advantages and limitations of artificial intelligence-integrated biosensors for next-generation point-of-care diagnostics, continuous health monitoring, and personalized healthcare applications.
Abstract
Biosensors have become important analytical platforms that enable rapid, selective, sensitive and portable analysis for early disease diagnosis, biomarker monitoring and point-of-care diagnostic applications. Their analytical performance depends on the coordinated function of molecular recognition elements, surface chemistry, transduction mechanisms and signal-processing strategies. Nevertheless, the analysis of real biological samples remains challenging because of low target concentrations, matrix effects, interfering species, signal noise, sensor drift and device-to-device variability. Therefore, artificial intelligence and machine learning are gaining increasing importance as data-driven tools for signal preprocessing, calibration, feature extraction, pattern recognition, quantitative prediction and diagnostic decision support. These approaches are particularly valuable for interpreting complex datasets generated by electrochemical, optical, wearable and microfluidic biosensors. This review presents an overview of healthcare-oriented biosensor systems beginning with molecular recognition principles, bioreceptor design, and transduction technologies, and extending to applications in clinical diagnosis and health monitoring. It also examines the roles of supervised, unsupervised and deep learning approaches in biosensor data analysis, while critically discussing model validation, generalizability, interpretability and clinical translation. By linking molecular-level recognition with computational signal interpretation, this review highlights the advantages and limitations of artificial intelligence-integrated biosensors for next-generation point-of-care diagnostics, continuous health monitoring, and personalized healthcare applications.
Challenges remain in receptor stability, nanomaterial reproducibility, large-scale manufacturing, regulatory approval, AI transparency, and sustainable disposal of single-use sensors.
S. Verma· International Journal of Mod...· 0 citations
This review provides a critical chemistry-to-clinical perspective on smart wearable biosensors and outlines the validation, manufacturing, cybersecurity, post-market surveillance and benchmarking requirements needed for their translation into reliable diagnostic and therapeutic-monitoring technologies.
Yachana Misha, Radheshyam Jena, Aman Shukla et al.· RSC Advances· 0 citations
Clinical translation remains limited by data security and privacy risks, insufficient standardization and regulatory alignment, long-term stability and biocompatibility concerns, and uneven validation maturity across technologies.
Ji-Rui Wen, Jiang Wu, Yi Yang et al.· Chinese Medical Journal· 0 citations
A multimodal explainable artificial intelligence framework for real-time cellular biosensing in intelligent healthcare systems is proposed and demonstrate that the proposed multimodal model achieves improved predictive performance compared with traditional machine learning and single-modality deep learning approaches.
Xinran Wang, Ethan Lin, M. Wang et al.· International Conference on...· 0 citations
Functionalized design is presented as an application‐backward, cross‐scale framework that links clinical needs and biomarker–matrix constraints with recognition chemistry, biointerfaces, functional materials, transduction architectures, calibration, data interpretation, manufacturability, and validation.
Ya-Nan Li, Yang Zhou, Meng Yang et al.· Advanced Materials & Technol...· 0 citations
This review summarizes relevant biosensor types, including electrochemical, optical, mass-sensitive, microfluidic, nano-biosensors (recently developed), and hydrogel-based systems with discussion of their underlying analytical principles and performance for clinically important cancer biomarkers.